European Medicines Agency - Regulatory - Regulation of medicines

4 - Quality management



    Description

Name

 

BPCRN - Belgian Pediatric Clinical Research Network

Documented adherence to GCP guideline Yes All studies are conducted and monitored in compliance of all local and Belgian laws and regulations, including ICH-GCP, EU clinical trials directive, EU CTR, as well as EU Commission Ethics guideline.
Documented adherence to the ethical considerations for clinical trials in children Yes All research activities involving children are assessed by an independent and competent ethics committee. BPCRN ascertains that research for children is maximally promoted while - at all times - adhering to all relevant ethical principles, as stipulated in the mission statement of the organisation.
Documented adherence to ethical considerations Yes Multiple experts from the network are involved in local ethic committees
Availability of Standard Operating Procedures (SOP) Yes
Capacity to monitor studies
(academic trials industry sponsored trials)
Yes We have direct contacts within our study sites and have reliable external partners for high quality ICH-GCP valid monitoring services upon request
Capacity to monitor performance of collaborating centres Yes
Quality control and quality assurance, raceability and data safety Yes We adhere to all principles related to the framework for Good Research Practice as stipulated by our host institution (https://www.ugent.be/en/research/framework/overview.htm). As such, our Research Data Management (RDM) plan entails all actions needed to ensure that data are secure, easy to find, understand, and (re)use, not only during a research project, but also in the longer term (according to https://www.ugent.be/en/research/openscience/datamanagement)